Biological characteristics of γδT cells and application in tumor immunotherapy

被引：6
|
作者：
Zhu, Renhong [1 ,2 ]
Yan, Qian [3 ]
Wang, Yashu [4 ]
Wang, Keqiang [1 ]
机构：
[1] Shandong First Med Univ, Dept Lab Med, Affiliated Hosp 2, Tai An, Peoples R China
[2] Taian Tumor Prevent & Treatment Hosp, Dept Lab Med, Tai An, Peoples R China
[3] Second Hosp Tradit Chinese Med, Dept Lab Med, Tai An, Peoples R China
[4] Qingdao Univ, Dept Lab Med, Affiliated Taian City Cent Hosp, Tai An, Peoples R China
来源：
FRONTIERS IN GENETICS | 2023年 / 13卷
基金：
中国国家自然科学基金;
关键词：
gamma delta T cells; tumor; immunotherapy; progress; biological; BISPHOSPHONATE ZOLEDRONIC ACID; HUMAN NATURAL-KILLER; STEM-LIKE CELLS; ALPHA-BETA; PERIPHERAL-BLOOD; ADOPTIVE IMMUNOTHERAPY; HEPATOCELLULAR-CARCINOMA; CELLULAR IMMUNOTHERAPY; CHEMOTHERAPY IMPROVES; DENDRITIC CELLS;
D O I：
10.3389/fgene.2022.1077419
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
Human gamma delta T cells are a special immune cell type which exist in small quantities in the body, do not require processing and presentation for antigen recognition, and have non-major histocompatibility complex (MHC)-restricted immune response. They play an important role in the body's anti-tumor, anti-infection, immune regulation, immune surveillance and maintenance of immune tolerance. This article reviews the generation and development of human gamma delta T cells, genetic characteristics, classification, recognition and role of antigens, and research progress in tumor immunotherapy.
引用
收藏
页数：14
相关论文
共 50 条
  • [31] Tumor-associated antigen specific CD8+ T cells in hepatocellular carcinoma - a promising target for immunotherapy
    Schmidt, Nathalie
    Flecken, Tobias
    Thimme, Robert
    ONCOIMMUNOLOGY, 2014, 3 (09)
  • [32] Potential of gamma/delta T cells for solid tumor immunotherapy
    Zhu, Dantong
    Ren, Xijing
    Xie, Wanting
    Chen, Jianjun
    Liang, Shiying
    Jiang, Mingzhe
    Wang, Junyi
    Zheng, Zhendong
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [33] Function and clinical application of exosome-how to improve tumor immunotherapy?
    Qin, Siwen
    Cao, Jilong
    Ma, Xiaoxue
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
  • [34] Function of γδ T cells in tumor immunology and their application to cancer therapy
    Park, Jang Hyun
    Lee, Heung Kyu
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2021, 53 (03) : 318 - 327
  • [35] Nanovaccine Showing Potent Immunotherapy to Tumor by Activating ΓδT Cells
    Yang, Zeyu
    Li, Liyan
    Wei, Chengxiu
    Liu, Hong
    Qiao, Dongdong
    Wen, Zhenfu
    Chen, Haolin
    Huang, Shanghui
    Guo, Rui
    Yin, Zhinan
    Liu, Lixin
    Chen, Yongming
    ADVANCED FUNCTIONAL MATERIALS, 2023, 33 (44)
  • [36] Natural Killer Cells and Current Applications of Chimeric Antigen Receptor-Modified NK-92 Cells in Tumor Immunotherapy
    Zhang, Jianguang
    Zheng, Huifang
    Diao, Yong
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (02):
  • [37] Engineering the Bridge between Innate and Adaptive Immunity for Cancer Immunotherapy: Focus on γδ T and NK Cells
    Morandi, Fabio
    Yazdanifar, Mahboubeh
    Cocco, Claudia
    Bertaina, Alice
    Airoldi, Irma
    CELLS, 2020, 9 (08)
  • [38] Local γδ T cells: translating promise to practice in cancer immunotherapy
    Zlatareva, Iva
    Wu, Yin
    BRITISH JOURNAL OF CANCER, 2023, 129 (03) : 393 - 405
  • [39] γδ T Cells and Tumor Microenvironment: From Immunosurveillance to Tumor Evasion
    Lo Presti, Elena
    Pizzolato, Gabriele
    Corsale, Anna Maria
    Caccamo, Nadia
    Sireci, Guido
    Dieli, Francesco
    Meraviglia, Serena
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [40] Human γδ T cells: From a neglected lymphocyte population to cellular immunotherapy: A personal reflection of 30 years of γδ T cell research
    Kabelitz, Dieter
    CLINICAL IMMUNOLOGY, 2016, 172 : 90 - 97
12345